2019 Clinical Trials Collective Data 
Cannabis Law Report
JUNE 2, 2021
Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. Department of Veteran Affairs’ most recent data. 1, 2019, the day legal sales began, and Sept. 1, 2019, the day legal sales began, and Sept.
SpeedWeed
MARCH 30, 2021
THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Project CBD
MARCH 21, 2023
I nterestingly, and perhaps unfortunately for patients, previous reviews in 2020 and 2019 2 also concluded there was insufficient evidence that cannabis can diminish chronic tinnitus. While the collective evidence to date is mixed and inconclusive, it’s also incomplete. 32,1 (2019): 131-136. A review of the current literature.”
Cannabis Law Report
JUNE 19, 2022
Partnership will focus on the collection and analysis of digital biomarkers to identify signs of response and relapse in upcoming Phase 2 clinical trials. However, we need rigorous clinical trials to ensure that this promise is realised. June 14, 2022 02:00 AM Eastern Daylight Time.
Cannabis Law Report
AUGUST 2, 2021
The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.
The Blunt Truth
AUGUST 13, 2019
In March of 2019, the FDA established a Working Group to determine the possible legislative pathways to regulate CBD. On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety.
The Joint Blog
FEBRUARY 24, 2021
Though trialing is relatively new and there is no clear scientific evidence as of yet, anecdotal evidence from patients is looking positive. In 2019 Parkinson’s UK published feedback given by 1,600 Parkinson’s sufferers and 29 health care professionals. This trial was to take 3.5
Expert insights. Personalized for you.
105 
Let's personalize your content